The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-hydroxyphenyl)-1-[2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxyphenyl]propan-1-one ID: ALA4552590
PubChem CID: 155556004
Max Phase: Preclinical
Molecular Formula: C21H24O8
Molecular Weight: 404.42
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CCc1ccc(O)cc1)c1ccccc1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
Standard InChI: InChI=1S/C21H24O8/c22-11-17-18(25)19(26)20(27)21(29-17)28-16-4-2-1-3-14(16)15(24)10-7-12-5-8-13(23)9-6-12/h1-6,8-9,17-23,25-27H,7,10-11H2/t17-,18-,19+,20-,21-/m1/s1
Standard InChI Key: UAFIADONBJJDTB-YMQHIKHWSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
8.8144 -6.4803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5224 -6.0731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2307 -6.4797 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2307 -7.2992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5249 -7.7057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8144 -7.3044 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5224 -5.2536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8143 -4.8418 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.2304 -4.8418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9426 -5.2536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6507 -4.8418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6510 -4.0223 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3566 -3.6173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0691 -4.0252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0672 -4.8388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3631 -5.2561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7772 -3.6175 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1063 -6.0726 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3941 -6.4803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3941 -7.2997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6861 -7.7074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9780 -7.2997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9780 -6.4803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6860 -6.0726 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2699 -6.0726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2699 -5.2532 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2699 -7.7074 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6861 -8.5268 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1063 -7.7074 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
2 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
10 11 1 0
12 11 2 0
13 12 1 0
14 13 2 0
15 14 1 0
16 15 2 0
11 16 1 0
14 17 1 0
1 18 1 0
19 18 1 1
20 19 1 0
21 20 1 0
22 21 1 0
23 22 1 0
24 23 1 0
19 24 1 0
23 25 1 1
25 26 1 0
22 27 1 6
21 28 1 1
20 29 1 6
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 404.42Molecular Weight (Monoisotopic): 404.1471AlogP: 0.39#Rotatable Bonds: 7Polar Surface Area: 136.68Molecular Species: NEUTRALHBA: 8HBD: 5#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 5#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.50CX Basic pKa: ┄CX LogP: 0.93CX LogD: 0.93Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.42Np Likeness Score: 1.25
References 1. Romero FA, Jones CT, Xu Y, Fenaux M, Halcomb RL.. (2020) The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease., 63 (10): [PMID:31930920 ] [10.1021/acs.jmedchem.9b01701 ]